Department of Medicine C, Meir Medical Center, Israel.
Eur J Intern Med. 2011 Dec;22(6):e87-9. doi: 10.1016/j.ejim.2011.08.023. Epub 2011 Sep 16.
Vena cava filters (VCFs) are used to prevent pulmonary embolism when anticoagulation is contraindicated or in the event of progression of thrombosis despite adequate anticoagulation. Retrievable VCFs provide a potential advantage over permanent VCFs, but the appropriateness of their use and the frequency with which they are removed is not well established.
Document the indications for insertion of retrievable VCFs, filter removal in hospital practice.
Observational study conducted in three academic medical centers. Consecutive patients undergoing retrievable VCF insertion were identified. Clinical data was extracted from the patients' charts and follow up data were obtained from treating physicians after discharge.
300 patients were studied. The indication for filter insertion was acute bleeding (46.1%) or surgery (24.2%) in patients with acute thrombosis, prevention of venous thromboembolism in trauma (13.3%), potential bleeding in patients with deep vein thrombosis (9.1%) thromboembolism while on adequate anticoagulation (5.7%) and other (1.3%). 21 (7%) filters were removed. An unsuccessful attempt at retrieval was undertaken in a further 9 (3%) patients.
The use of retrievable VCFs was appropriate, with the possible exception of their prophylactic use in major trauma. The majority of VCFs were not removed, for reasons that are not apparent.
记录可回收静脉滤器置入的适应证,以及在医院实践中滤器的取出情况。
在 3 所学术医学中心进行观察性研究。确定接受可回收静脉滤器置入的连续患者。从患者的病历中提取临床数据,并在出院后从治疗医生处获得随访数据。
共研究了 300 例患者。滤器置入的适应证为急性血栓形成患者的急性出血(46.1%)或手术(24.2%)、急性创伤患者的静脉血栓栓塞预防(13.3%)、深静脉血栓形成患者的潜在出血(9.1%)、充分抗凝治疗期间发生血栓栓塞(5.7%)和其他(1.3%)。21 例(7%)滤器被取出。另外 9 例(3%)患者尝试取栓失败。
可回收静脉滤器的使用是合理的,可能除了在重大创伤中预防性使用之外。大多数静脉滤器没有取出,原因尚不清楚。